El Guerrouj emphasized that Morocco’s ambitious cannabis regulation project continues to move forward “with calm and responsibility,” striking a balance between public health priorities and emerging economic opportunities. He noted that, to date, 109 CBD-based cannabis products have been manufactured by authorized pharmaceutical companies and operators. These products have been registered with the Moroccan Agency for Medicines and Health Products and approved for distribution on the national market. He highlighted a fundamental shift in how cannabis-derived compounds are approached, noting that they are now studied through scientific, pharmacological, and therapeutic lenses. He also highlighted the importance of scientific societies, stressing that scientific evidence must remain the guiding principle in developing therapeutic cannabis use.